Marco R Schroeter
Overview
Explore the profile of Marco R Schroeter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schroeter M, Klingel K, Korsten P, Hasenfuss G
Eur Heart J Case Rep
. 2022 Mar;
6(3):ytac062.
PMID: 35291336
Background: Lyme disease is a tick-borne multisystem infection. The most common cardiac manifestation is an acute presentation of Lyme carditis, which often manifests as conduction disorder and rarely as myocarditis....
2.
Schnieder M, von Glasenapp A, Hesse A, Psychogios M, Bahr M, Hasenfuss G, et al.
Stroke Res Treat
. 2019 Aug;
2019:4695414.
PMID: 31467659
The impact of heart failure on outcome in stroke patients is not fully understood. There is evidence for an increased mortality and morbidity, but it remains uncertain whether thrombectomy in...
3.
Schnieder M, Siddiqui T, Karch A, Bahr M, Hasenfuss G, Schroeter M, et al.
Int J Stroke
. 2018 Nov;
14(4):423-429.
PMID: 30480476
Background: About 25% of strokes are thought to be cryptogenic. There is growing evidence that most of these cryptogenic strokes are thromboembolic and caused by an undetected atrial fibrillation. Measured...
4.
Schnieder M, Siddiqui T, Karch A, Bahr M, Hasenfuss G, Liman J, et al.
Eur Neurol
. 2017 Sep;
78(5-6):264-269.
PMID: 28957815
Background: A significant proportion of ischemic strokes are cryptogenic. In this context, the clinical pertinence of patent foramen ovale (PFO) with and without atrial septum aneurysm (ASA) remains controversial. The...
5.
Hellenkamp K, Becker A, Gabriel Y, Hasenfuss G, Hunlich M, Jacobshagen C, et al.
Int J Cardiol
. 2017 Mar;
234:58-63.
PMID: 28258843
Background: Bioresorbable vascular scaffolds (BVS) are widely used in routine clinical practice. While previous studies reported acceptable short- to midterm outcome after BVS implantation, data on longer-term outcome are rare....
6.
Schroeter M, Schillinger W
Case Rep Cardiol
. 2016 Nov;
2016:8438923.
PMID: 27800191
The Amplatzer Cardiac Plug (ACP) is one of the most commonly used devices for percutaneous left atrial appendage (LAA) closure in order to prevent a stroke in patients with atrial...
7.
Gogiraju R, Schroeter M, Bochenek M, Hubert A, Munzel T, Hasenfuss G, et al.
Cardiovasc Res
. 2016 May;
111(3):204-16.
PMID: 27207947
Aims: Cardiac angiogenesis is an important determinant of heart failure. We examined the hypothesis that protein tyrosine phosphatase (PTP)-1B, a negative regulator of vascular endothelial growth factor (VEGF) receptor-2 activation,...
8.
Schroeter M, Danner B, Hunlich M, Schillinger W
Clin Res Cardiol
. 2013 Dec;
103(4):285-90.
PMID: 24310111
Aims: Percutaneous left atrial appendage closure with Amplatzer(®) Cardiac Plug (St. Jude Medical Inc.) for the prevention of stroke in patients with atrial fibrillation is rapidly propagating. We sought to...
9.
Schroeter M, Koziolek M
Clin Res Cardiol
. 2013 Nov;
103(1):79-81.
PMID: 24249314
No abstract available.
10.
Czepluch F, Bernhardt M, Kuschicke H, Gogiraju R, Schroeter M, Riggert J, et al.
Microcirculation
. 2013 Oct;
21(2):148-58.
PMID: 24125396
Objective: Human monocytes can be divided into CD16(-) monocytes and CD16(+) monocytes. Studies in mice suggested differential effects of monocyte subsets during new vessel formation. Methods: The functional role of...